Measurement of the total proANP product in mammals by processing independent analysis

Journal of Immunological Methods

Volumn 370, Issue 1-2, 2011, Pages 104-110

  Hunter, Ingrid ^a,b   Rehfeld, Jens F ^a   Goetze, Jens P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ANP; BNP; Natriuretic peptide; Proanp; Probnp

Indexed keywords

ATRIAL NATRIURETIC FACTOR; EPITOPE; PRO ATRIAL NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; AGING; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOG; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SWINE;

AMINO ACID SEQUENCE; ANIMALS; ATRIAL NATRIURETIC FACTOR; HEART FAILURE; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT;

CANIS FAMILIARIS; MAMMALIA; SUIDAE; SUS;

EID: 79960066168     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.06.005     Document Type: Article

References (30)

1. Alehagen U., Goetze J.P., Dahlström U. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly. Clin. Chim. Acta 2007, 382:8.
2. Bardram L., Rehfeld J.F. Processing-independent radioimmunoanalysis: a general analytical principle applied to progastrin and its products. Anal. Biochem. 1988, 175:537.
3. Burnett J.C., Kao P.C., Hu D.C., Heser D.W., Heublein D., Granger J.P., et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986, 231:1145.
4. Chen Y.M., Whitson P.A., Cintrón N.M. Immunoreactive prohormone atrial natriuretic peptides 1-30 and 31-67; existence of a single circulating amino-terminal peptide. Biochem. Biophys. Res. Commun. 1990, 166:794.
5. Christoffersen C., Goetze J.P., Bartels E.D., Larsen M.O., Ribel U., Rehfeld J.F., et al. Chamber-dependent expression of brain natriuretic peptide and its mRNA in normal and diabetic pig heart. Hypertension 2002, 40:54.
6. Daniels L.B., Maisel A.S. Natriuretic peptides. J. Am. Coll. Cardiol. 2007, 50:2357.
7. Goetze J.P. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin. Chem. 2004, 50:1503.
8. Goetze J.P. Biosynthesis of cardiac natriuretic peptides. Results Probl. Cell Differ. 2010, 50:97.
9. Goetze J.P., Rehfeld J.F., Videbaek R., Friis-Hansen L., Kastrup J. B-type natriuretic peptide and its precursor in cardiac venous blood from failing hearts. Eur. J. Heart Fail. 2005, 7:69.
10. Goetze J.P., Hansen C.P., Rehfeld J.F. Antral content, secretion and peripheral metabolism of N-terminal progastrin fragments. Regul. Pept. 2006, 133:47.
11. Goetze J.P., Dahlström U., Rehfeld J.F., Alehagen U. Impact of epitope specificity and precursor maturation in pro-B-type natriuretic peptide measurement. Clin. Chem. 2008, 54:1780.
12. Goetze J.P., Georg B., Jørgensen H.L., Fahrenkrug J. Chamber-dependent circadian expression of cardiac natriuretic peptides. Regul. Pept. 2010, 160:140.
13. Hunt P.J., Richards A.M., Nicholls M.G., Yandle T.G., Doughty R.N., Espiner E.A. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin. Endocrinol. 1997, 47:287.
14. Hystad M.E., Klinge R., Spurkland A., Attramadal H., Hall C. Contrasting cardiac regional responses of A-type and B-type natriuretic peptide to experimental chronic heart failure. Scand. J. Clin. Lab. Invest. 2000, 60:299.
15. Maisel A., Mueller C., Adams K., Anker S.D., Aspromonte N., Cleland J.G., et al. State of the art: using natriuretic peptide levels in clinical practice. Eur. J. Heart Fail. 2008, 10:824.
16. Maisel A., Mueller C., Nowak R., Peacock W.F., Landsberg J.W., Ponikowski P., et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J. Am. Coll. Cardiol. 2010, 55:2062.
17. Moertl D., Berger R., Struck J., Gleiss A., Hammer A., Morgenthaler N.G., et al. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death. J. Am. Coll. Cardiol. 2009, 53:1783.
18. Morgenthaler N.G., Struck J., Thomas B., Bergmann A. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin. Chem. 2004, 50:234.
19. Mukoyama M., Nakao K., Hosoda K., Suga S., Saito Y., Ogawa Y., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991, 87:1402.
20. Nahm M.H., Herzenberg L.A., Little K., Little J.R. A new method of applying the Sips equation. J. Immunol. 1977, 119:301.
21. Nishikimi T., Maeda N., Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc. Res. 2006, 69:318.
22. Pan S., Chen H.H., Dickey D.M., Boerrigter G., Lee C., Kleppe L.S., et al. Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:11282.
23. Rehfeld J.F., Goetze J.P. The posttranslational phase of gene expression: new possibilities in molecular diagnosis. Curr. Mol. Med. 2003, 3:25.
24. Richards A.M. Natriuretic peptides: update on peptide release, bioactivity, and clinical use. Hypertension 2007, 50:25.
25. Schellenberger U., O'Rear J., Guzzetta A., Jue R.A., Protter A.A., Pollitt N.S. The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch. Biochem. Biophys. 2006, 451:160.
26. Semenov A.G., Postnikov A.B., Tamm N.N., Seferian K.R., Karpova N.S., Bloshchitsyna M.N., et al. Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clin. Chem. 2009, 55:489.
27. Stadil F., Rehfeld J.F. Preparation of 125 I-labelled synthetic human gastrin I for radioimmunoanalysis. Scand. J. Clin. Lab. Invest. 1972, 30:361.
28. Steiner D.F. The proinsulin C-peptide-a multirole model. Exp. Diabesity Res. 2004, 5:7.
29. Tarnow I., Olsen L.H., Kvart C., Hoglund K., Moesgaard S.G., Kamstrup T.S., et al. Predictive value of natriuretic peptides in dogs with mitral valve disease. Vet. J. 2009, 180:195.
30. Von Haehling S., Jankowska E.A., Morgenthaler N.G., Vassanelli C., Zanolla L., Rozentryt P., et al. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J. Am. Coll. Cardiol. 2007, 50:1973.